Bayesian Capital Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$408K Buy
+10,100
New +$451K 0.33% 88
2025
Q4
– Sell
-9,625
Closed -$433K – 264
2025
Q3
$433K Buy
+9,625
New +$423K 0.09% 308
2025
Q1
– Sell
-164,100
Closed -$6.18M – 721
2024
Q4
$6.18M Buy
+164,100
New +$6.37M 0.76% 11
2023
Q3
– Sell
-47,200
Closed -$1.92M – 787
2023
Q2
$1.92M Buy
+47,200
New +$1.95M 0.21% 133
2021
Q3
– Sell
-16,263
Closed -$514K – 432
2021
Q2
$514K Buy
+16,263
New +$524K 0.13% 186
2021
Q1
– Sell
-26,918
Closed -$811K – 582
2020
Q4
$811K Buy
+26,918
New +$794K 0.21% 134
2019
Q3
– Sell
-57,622
Closed -$1.97M – 571
2019
Q2
$1.97M Buy
+57,622
New +$2.03M 0.41% 67
2018
Q4
– Sell
-14,861
Closed -$463K – 658
2018
Q3
$463K Buy
+14,861
New +$457K 0.08% 352

Other funds holding EXC

Bayesian Capital Management's EXC Position: Q3 2026 in Review

Bayesian Capital Management opened a new position in Exelon (EXC) in Q3 2026: 10,100 shares worth $408K. The stake represents 0.33% of the portfolio and ranks #88 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in EXC as recently as Q3 2025.

Bayesian Capital Management first reported a position in EXC in Q3 2018 and has held it in 8 quarters since. The position peaked at $6.18M in Q4 2024. 1,249 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • Bayesian Capital Management held 10,100 shares of Exelon worth $408K as of Q3 2026.
  • Exelon was a new Bayesian Capital Management position in Q3 2026.
  • Exelon made up 0.33% of Bayesian Capital Management's portfolio in Q3 2026, its #88 holding.
  • Bayesian Capital Management first reported a position in Exelon in Q3 2018 and has held it in 8 quarters since.
  • Bayesian Capital Management's Exelon position peaked at $6.18M in Q4 2024.
  • 1,249 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on Bayesian Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.